| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.009 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |